12:00 AM
Sep 17, 2012
 |  BC Week In Review  |  Company News  |  Deals

Pfizer, Zhejiang Hisun Pharmaceutical deal

The partners launched Hisun-Pfizer Pharmaceuticals Co. Ltd., a JV to develop and commercialize generics in China and other worldwide markets. Located in Fuyang, China, the JV has an aggregate investment of $295 million and $250...

Read the full 151 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >